Grim19 attenuates DSS induced colitis in an animal model

Citations of this article
Mendeley users who have this article in their library.


{D\SS} induced colitis is a chronic inflammatory disease characterized by inflammation in the gastrointestinal tract, which destabilizes the gut and induces an uncontrolled immune response. Although {D\SS} induced colitis is generally thought to develop as a result of an abnormally active intestinal immune system, its pathogenesis remains unclear. Gene associated with retinoid interferon induced mortality (Grim) 19 is an endogenous specific inhibitor of {STAT3}, which regulates the expression of proinflammatory cytokines. In this study, we investigated the influence of {GRIM19} in a {D\SS} induced colitis mouse model. We hypothesized that Grim19 would ameliorate {D\SS} induced colitis by altering {STAT3} activity and intestinal inflammation. Grim19 ameliorated {D\SS} induced colitis severity and protected intestinal tissue. The expression of {STAT3} and proinflammatory cytokines such as {IL}-1βand {TNF}-αin colon and lymph nodes was decreased significantly by Grim19. Moreover, {D\SS} induced colitis progression in a Grim19 transgenic mouse line was inhibited in association with a reduction in {STAT3} and {IL}-17 expression. These results suggest that Grim19 attenuates {D\SS} induced colitis by suppressing the excessive inflammatory response mediated by {STAT3} activation.




Kim, J. K., Lee, S. H., Lee, S. Y., Kim, E. K., Kwon, J. E., Seo, H. B., … Cho, M. L. (2016). Grim19 attenuates DSS induced colitis in an animal model. PLoS ONE, 11(6).

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free